Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Enzalutamide> ?p ?o. }
Showing items 1 to 60 of
60
with 100 items per page.
- Enzalutamide abstract "Enzalutamide (marketed as Xtandi and formerly known as MDV3100) is an androgen receptor antagonist drug developed by the pharmaceutical company Medivation for the treatment of metastatic castration-resistant prostate cancer. Medivation has reported up to an 89% decrease in prostate specific antigen serum levels after a month of taking the medicine. Early preclinical studies also suggest that enzalutamide inhibits breast cancer cell growth. In August 2012, the U.S. Food and Drug Administration approved enzalutamide for the treatment of castration-resistant prostate cancer.".
- Enzalutamide atcPrefix "None".
- Enzalutamide casNumber "915087-33-1".
- Enzalutamide chEBI "68534".
- Enzalutamide fdaUniiCode "93T0T9GKNU".
- Enzalutamide iupacName "4-(3-(4-Cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluoro-N-methylbenzamide".
- Enzalutamide pubchem "15951529".
- Enzalutamide thumbnail Enzalutamide-01.svg?width=300.
- Enzalutamide wikiPageID "18066455".
- Enzalutamide wikiPageRevisionID "591214124".
- Enzalutamide atcPrefix "None".
- Enzalutamide c "21".
- Enzalutamide casNumber "915087".
- Enzalutamide chebi "68534".
- Enzalutamide chemspiderid "13093347".
- Enzalutamide f "4".
- Enzalutamide h "16".
- Enzalutamide hasPhotoCollection Enzalutamide.
- Enzalutamide iupacName "4".
- Enzalutamide legalUs "Rx-only".
- Enzalutamide licenceUs "Enzalutamide".
- Enzalutamide molecularWeight "464.44".
- Enzalutamide n "4".
- Enzalutamide o "2".
- Enzalutamide pregnancyUs "X".
- Enzalutamide pubchem "15951529".
- Enzalutamide routesOfAdministration "Oral".
- Enzalutamide s "1".
- Enzalutamide smiles "N#Cc1ccccc1".
- Enzalutamide stdinchi "1".
- Enzalutamide stdinchikey "WXCXUHSOUPDCQV-UHFFFAOYSA-N".
- Enzalutamide tradename "Xtandi".
- Enzalutamide unii "93".
- Enzalutamide width "250".
- Enzalutamide subject Category:Antiandrogens.
- Enzalutamide subject Category:Benzamides.
- Enzalutamide subject Category:Drugs.
- Enzalutamide subject Category:Experimental_cancer_drugs.
- Enzalutamide subject Category:Imidazolidines.
- Enzalutamide subject Category:Lactams.
- Enzalutamide subject Category:Nitriles.
- Enzalutamide subject Category:Organofluorides.
- Enzalutamide subject Category:Thioureas.
- Enzalutamide type Drug.
- Enzalutamide type FunctionalSubstance.
- Enzalutamide comment "Enzalutamide (marketed as Xtandi and formerly known as MDV3100) is an androgen receptor antagonist drug developed by the pharmaceutical company Medivation for the treatment of metastatic castration-resistant prostate cancer. Medivation has reported up to an 89% decrease in prostate specific antigen serum levels after a month of taking the medicine. Early preclinical studies also suggest that enzalutamide inhibits breast cancer cell growth. In August 2012, the U.S.".
- Enzalutamide label "Enzalutamid".
- Enzalutamide label "Enzalutamide".
- Enzalutamide label "Enzalutamide".
- Enzalutamide label "MDV3100".
- Enzalutamide sameAs Enzalutamid.
- Enzalutamide sameAs Enzalutamida.
- Enzalutamide sameAs Enzalutamide.
- Enzalutamide sameAs MDV3100.
- Enzalutamide sameAs m.047rn4_.
- Enzalutamide sameAs Q1996756.
- Enzalutamide sameAs Q1996756.
- Enzalutamide wasDerivedFrom Enzalutamide?oldid=591214124.
- Enzalutamide depiction Enzalutamide-01.svg.
- Enzalutamide isPrimaryTopicOf Enzalutamide.